Supreme Court restores mifepristone access by mailnews2026-05-04T16:14:14+00:00May 4th, 2026|Endpoints News|
Moderna in talks with FDA over Phase 4 Covid vaccine datanews2026-05-01T18:08:48+00:00May 1st, 2026|Endpoints News|
FDA approves Pfizer and Arvinas’ breast cancer drug despite underwhelming datanews2026-05-01T17:33:49+00:00May 1st, 2026|Endpoints News|
Samsung Biologics workers begin five-day strike over wage disputes news2026-05-01T16:13:17+00:00May 1st, 2026|Endpoints News|
Court dismisses part of Lilly lawsuit against Empower, some claims can proceednews2026-04-30T18:16:20+00:00April 30th, 2026|Endpoints News|
Supreme Court questions how far generics makers can go with ‘skinny label’ drugsnews2026-04-30T18:10:37+00:00April 30th, 2026|Endpoints News|
Analysts focus on three programs in big year for Bristol Myersnews2026-04-30T15:33:19+00:00April 30th, 2026|Endpoints News|
Updated: Early sales of Lilly’s obesity pill appear to trail Novo’snews2026-04-30T11:19:05+00:00April 30th, 2026|Endpoints News|
The R&D 15: How pharma’s top companies spent, won and lost on drug researchnews2026-04-30T11:15:51+00:00April 30th, 2026|Endpoints News|
Novartis unveils North Carolina factory as final new build in $23B US expansionnews2026-04-30T11:00:00+00:00April 30th, 2026|Endpoints News|
